Entering text into the input field will update the search result below

Illumina, German hospital team up for genome sequencing to test genetic disease in ill children

Apr. 25, 2022 6:42 AM ETIllumina, Inc. (ILMN) StockBy: Ravikash Bakolia, SA News Editor

Blue chromosome DNA and gradually glowing flicker light matter chemical when camera moving closeup. Medical and Heredity genetic health concept. Technology science. 3D illustration rendering

Shutter2U/iStock via Getty Images

  • Illumina (NASDAQ:ILMN) signed an agreement with Germany's Hannover Medical School to implement the use of whole-genome sequencing (WGS) in critically ill children suspected of having a genetic or rare disease.
  • The company noted that WGS

Recommended For You

More Trending News

About ILMN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ILMN--
Illumina, Inc.